Biotechnology Assets SA
MAD:BST

Watchlist Manager

Biotechnology Assets SA

MAD:BST

Watchlist

Dividends

Discount Rate

Price: 0.29 EUR -0.68%

Market Cap: 18.9m EUR

Have any thoughts about
Biotechnology Assets SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 0.29 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BST Alert

Biotechnology Assets SA

0.29

-0.002 (-0.68%)

52 Week Range	0.26 0.432
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Biotechnology Assets SA

What unique competitive advantages
does Biotechnology Assets SA hold over its rivals?

What risks and challenges
does Biotechnology Assets SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Biotechnology Assets SA.

What unique competitive advantages
does Biotechnology Assets SA hold over its rivals?

What risks and challenges
does Biotechnology Assets SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biotechnology Assets SA.

Provide P/S
for Biotechnology Assets SA.

Provide P/E
for Biotechnology Assets SA.

Provide P/OCF
for Biotechnology Assets SA.

Provide P/FCFE
for Biotechnology Assets SA.

Provide P/B
for Biotechnology Assets SA.

Provide EV/S
for Biotechnology Assets SA.

Provide EV/GP
for Biotechnology Assets SA.

Provide EV/EBITDA
for Biotechnology Assets SA.

Provide EV/EBIT
for Biotechnology Assets SA.

Provide EV/OCF
for Biotechnology Assets SA.

Provide EV/FCFF
for Biotechnology Assets SA.

Provide EV/IC
for Biotechnology Assets SA.

What are the Revenue projections
for Biotechnology Assets SA?

How accurate were the past Revenue estimates
for Biotechnology Assets SA?

What are the Net Income projections
for Biotechnology Assets SA?

How accurate were the past Net Income estimates
for Biotechnology Assets SA?

What are the EPS projections
for Biotechnology Assets SA?

How accurate were the past EPS estimates
for Biotechnology Assets SA?

What are the EBIT projections
for Biotechnology Assets SA?

How accurate were the past EBIT estimates
for Biotechnology Assets SA?

Compare the revenue forecasts
for Biotechnology Assets SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biotechnology Assets SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biotechnology Assets SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biotechnology Assets SA compared to its peers.

Compare the P/E ratios
of Biotechnology Assets SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biotechnology Assets SA with its peers.

Analyze the financial leverage
of Biotechnology Assets SA compared to its main competitors.

Show all profitability ratios
for Biotechnology Assets SA.

Provide ROE
for Biotechnology Assets SA.

Provide ROA
for Biotechnology Assets SA.

Provide ROIC
for Biotechnology Assets SA.

Provide ROCE
for Biotechnology Assets SA.

Provide Gross Margin
for Biotechnology Assets SA.

Provide Operating Margin
for Biotechnology Assets SA.

Provide Net Margin
for Biotechnology Assets SA.

Provide FCF Margin
for Biotechnology Assets SA.

Show all solvency ratios
for Biotechnology Assets SA.

Provide D/E Ratio
for Biotechnology Assets SA.

Provide D/A Ratio
for Biotechnology Assets SA.

Provide Interest Coverage Ratio
for Biotechnology Assets SA.

Provide Altman Z-Score Ratio
for Biotechnology Assets SA.

Provide Quick Ratio
for Biotechnology Assets SA.

Provide Current Ratio
for Biotechnology Assets SA.

Provide Cash Ratio
for Biotechnology Assets SA.

What is the historical Revenue growth
over the last 5 years for Biotechnology Assets SA?

What is the historical Net Income growth
over the last 5 years for Biotechnology Assets SA?

What is the current Free Cash Flow
of Biotechnology Assets SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biotechnology Assets SA.

Financials Section:

Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Cash Flow Statement
Biotechnology Assets SA

Rotate your device to view
Cash Flow Statement

Currency: EUR

	Dec-2017	Jun-2018	Dec-2018	Jun-2019	Dec-2019	Jun-2020	Dec-2020	Jun-2021	Dec-2021	Jun-2022	Dec-2022	Jun-2023	Dec-2023	Jun-2024
Operating Cash Flow
Net Income	(0)	(8)	(17)	(12)	0	(17)	0	0	0	0	0	0	0	0
Depreciation & Amortization	1	2	3	4	2	2	2	1	2	2	2	2	2	(0)
Other Non-Cash Items	0	2	2	1	(7)	4	(7)	(4)	1	0	0	(0)	0	0
Cash Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Interest Paid	0	0	1	1	2	4	0	(2)	1	0	0	0	0	0
Change in Working Capital	(1)	(1)	(1)	(3)	(10)	(3)	14	11	(4)	(4)	(2)	(2)	(3)	1
Cash from Operating Activities	0 N/A	(6) N/A	(13) -120%	(10) +23%	(15) -51%	(15) +3%	9 N/A	10 +16%	(2) N/A	(2) -21%	(0) +99%	0 N/A	0 -49%	1 +1 881%
Investing Cash Flow
Capital Expenditures	(2)	(4)	(11)	(9)	(7)	(9)	(0)	2	(1)	(1)	(2)	(2)	(0)	(0)
Other Items	0	2	2	0	0	0	45	45	0	0	0	(0)	0	(0)
Cash from Investing Activities	(1) N/A	(2) -39%	(10) -382%	(10) -1%	(7) +23%	(9) -19%	45 N/A	47 +5%	(1) N/A	(1) -8%	(2) -199%	(2) -8%	(0) +86%	0 N/A
Financing Cash Flow
Net Issuance of Common Stock	0	0	12	12	0	0	0	1	3	4	1	0	0	(0)
Net Issuance of Debt	2	7	12	11	23	24	(58)	(63)	0	0	(0)	(0)	(0)	0
Other	0	0	0	0	1	1	0	0	0	0	(0)	0	(0)	(0)
Cash from Financing Activities	2 N/A	7 +311%	24 +273%	23 -4%	24 +0%	24 +4%	(58) N/A	(62) -7%	3 N/A	4 +23%	1 -72%	0 -71%	(0) N/A	(0) -499%
Change in Cash
Effect of Foreign Exchange Rates	0	(0)	0	(0)	(0)	(0)	0	0	0	0	0	0	0	0
Net Change in Cash	0 N/A	(1) N/A	1 N/A	4 +144%	1 -77%	1 +5%	(4) N/A	(4) -5%	1 N/A	2 +36%	(1) N/A	(2) -87%	(0) +82%	1 N/A
Free Cash Flow
Free Cash Flow	(1) N/A	(10) -640%	(24) -143%	(19) +20%	(23) -17%	(24) -4%	8 N/A	12 +46%	(2) N/A	(3) -18%	(2) +16%	(2) +13%	(0) +85%	1 N/A

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Switch to:

Income Statement Balance Sheet Cash Flow Statement

	Franklin Covey Co NYSE:FC	36.3 USD -0.3%
	Mohawk Industries Inc NYSE:MHK	119.54 USD 0.32%
	Ardmore Shipping Corp NYSE:ASC	11.88 USD 5.04%
	ASGN Inc NYSE:ASGN	83.56 USD -0.37%
	Skyworks Solutions Inc NASDAQ:SWKS	90.19 USD 1.62%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.45%

	Johnson & Johnson NYSE:JNJ	145.27 USD 0.55%
	Bank of America Corp NYSE:BAC	43.89 USD -0.63%
	Mastercard Inc NYSE:MA	528.96 USD 0.18%
	Salesforce Inc NYSE:CRM	342.9 USD -0.22%
	Abbvie Inc NYSE:ABBV	178.39 USD 1.6%
	Home Depot Inc NYSE:HD	392.45 USD -0.04%

	Arista Networks Inc NYSE:ANET	113.09 USD 0.25%
	Visa Inc NYSE:V	317.22 USD -0.15%
	Texas Pacific Land Corp NYSE:TPL	1 139.45 USD 0.56%
	KLA Corp NASDAQ:KLAC	647.99 USD 2.96%
	Manhattan Associates Inc NASDAQ:MANH	278.82 USD -0.51%
	Pinduoduo Inc NASDAQ:PDD	100.58 USD 1.08%

	Salesforce Inc NYSE:CRM	342.9 USD -0.22%
	Accenture PLC NYSE:ACN	358.77 USD -2.07%
	ServiceNow Inc NYSE:NOW	1 088.26 USD -0.27%
	EOG Resources Inc NYSE:EOG	119.85 USD 0.68%
	Copart Inc NASDAQ:CPRT	58.36 USD 0.24%
	Applied Materials Inc NASDAQ:AMAT	167.46 USD 2.37%

Biotechnology Assets SA
MAD:BST

Cash Flow Statement

Cash Flow Statement
Biotechnology Assets SA

See Also

Company

Help

Tools

Stocks